Match tier Likely match
Presence Not recently confirmed
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Naveena Singh

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

Role not yet determined Is this you? Add your title

64 h-index 437 pubs 16,943 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 135 institutions in 24 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

  • Humans
  • Female
  • Ovarian Neoplasms
  • Middle Aged
  • Aged
  • Endometrial Neoplasms
  • Adult
  • Immunohistochemistry
  • Cystadenocarcinoma, Serous
  • Biomarkers, Tumor
  • Neoplasm Staging
  • Tumor Suppressor Protein p53
  • Prognosis
  • Early Detection of Cancer
  • Mutation

Biography and Research Information

OverviewAI-generated summary

Naveena Singh's research focuses on gynecological oncology, particularly the screening, molecular classification, and treatment of ovarian and endometrial cancers. She has contributed to significant studies examining the efficacy of ovarian cancer screening programs, such as the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), investigating its impact on mortality and the distribution of detected cancer stages.

Her work also delves into the molecular characteristics of high-risk endometrial cancer, as evidenced by her involvement in the PORTEC-3 trial. This research explores the prognostic implications of molecular subtyping and the benefits of adjuvant therapies, including chemoradiotherapy. Singh has also investigated the role of tumor-infiltrating lymphocytes as a prognostic factor in high-grade serous ovarian cancer. Her extensive publication record, high citation count, and designation as a highly cited researcher underscore the impact of her contributions to the field of gynecological cancer research.

Metrics

  • h-index: 64
  • Publications: 437
  • Citations: 16,943

Selected Publications

  • A28-06 Sex Differences in Acute Pulmonary Embolism Outcomes Among African American Patients With Sickle Cell Disease: A National Estimate (2026)
  • C54-21 Demographic and Mortality Differences Between Intensive Care and Non-intensive Care Admissions for Pseudomonas Sepsis in Chronic Lymphocytic Leukemia Patients (2026)
  • C27-12 Pneumocystis Jirovecii Pneumonia Among Cancer Patients: Comparing Outcomes Between Solid Tumors and Hematologic Malignancies (2026)
  • A80-3-32 When the Effusion Lies: Mesothelioma Revealed by Lymph Node Biopsy (2026)
  • A67-11 Catheter-Directed Thrombolysis in Recurrent Versus First-Time Pulmonary Embolism: Comparing Complications, Mortality, and Readmissions (2026)
  • A72-04 The Mucus Plug That Unmasked a Congenital Secret: A Case of Bronchial Atresia in an Adult Female (2026)
  • B80-4-40 Myth or Reality: The July Effect on Robotic-assisted Thoracoscopic Lung Resection in Malignant Lung Neoplasms at Urban Teaching Centers (2026)
  • A77-13 Prognostic Significance of Maximal Inspiratory Pressure and Maximal Expiratory Pressure in Neuromuscular Disorders: A Complex Case of Amyotrophic Lateral Sclerosis and Ryanodine Receptor 1-Associated Myopathy Leading to Accelerated Respiratory Failure (2026)
  • B42-23 Clinical Profile and Healthcare Burden of Isolated Pulmonary Sarcoidosis Versus Combined Pulmonary-Cardiac Sarcoidosis: A Nationwide Analysis (2026)

View all publications on OpenAlex →

Collaboration Network

14 Collaborators 11 Institutions 4 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics